Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder, Overactive

Explore clinical trials studying Urinary Bladder, Overactive. Study availability and eligibility vary by location and protocol.

609 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder, Overactive trial results

Completed

A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder

NCT00928070

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Montgomery, Alabama, United States
  • Pfizer Investigational Site Green Valley, Arizona, United States
View all 125 locations
View Trial Details
Completed

Vesitirim™ in Men Postmarketing Observational Study

NCT01639794

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Site 2 - Mercy University Hospital Cork, Ireland
  • Site: 4 - Tallaght Hospital Dublin, Ireland
  • Site: 1 - St James Hopsital Dublin, Ireland
  • Site: 5 - Beaumont Hospital Dublin, Ireland
View Trial Details
Completed

Clinical Trial to Study a Non-invasive Neurostimulation Device on Urgency (Urinary) Incontinence Overactive Bladder (OAB)

NCT01125722

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Medical Faculty Associates, The George Washington University Washington D.C., District of Columbia, United States
  • William Beaumont Hospital - Department of Urology Royal Oak, Michigan, United States
  • AdvanceMed Research Lawrenceville, New Jersey, United States
  • Delaware Valley Urology, LLC Mount Laurel, New Jersey, United States
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder

NCT00196404

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Duramed Investigational Site Birmingham, Alabama, United States
  • Duramed Investigational Site Huntsville, Alabama, United States
  • Duramed Investigational Site Mobile, Alabama, United States
  • Duramed Research Site Phoenix, Arizona, United States
View all 48 locations
View Trial Details
Completed

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

NCT00703703

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Healthy, +9 more
Locations
  • Investigative Site Phoenix, Arizona, United States
  • Investigative Site Tempe, Arizona, United States
  • Investigative Site Little Rock, Arkansas, United States
  • Investigative Site San Diego, California, United States
View all 21 locations
View Trial Details

Related conditions